Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control (2022)
Attributed to:
The generation and maintenance of genetic novelty in helminth populations
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(22)00369-3
PubMed Identifier: 35850127
Publication URI: http://europepmc.org/abstract/MED/35850127
Type: Journal Article/Review
Parent Publication: The Lancet Infectious Diseases
Issue: 11
ISSN: 1473-3099